CDCA8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.926400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.110200E-01
Normal-vs-Stage2
3.469600E-01
Normal-vs-Stage3
9.710200E-01
Normal-vs-Stage4
6.230600E-01
Stage1-vs-Stage2
4.076800E-01
Stage1-vs-Stage3
6.253800E-01
Stage1-vs-Stage4
8.533600E-01
Stage2-vs-Stage3
2.624400E-01
Stage2-vs-Stage4
6.229000E-01
Stage3-vs-Stage4
5.167000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.918400E-01
Normal-vs-AfricanAmerican
7.483400E-01
Normal-vs-Asian
3.318800E-01
Caucasian-vs-AfricanAmerican
4.152600E-01
Caucasian-vs-Asian
8.755600E-01
AfricanAmerican-vs-Asian
4.140200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.232000E-01
Normal-vs-Female
3.629600E-01
Male-vs-Female
8.116600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.823800E-01
Normal-vs-Age(41-60Yrs)
3.385200E-01
Normal-vs-Age(61-80Yrs)
4.402400E-01
Normal-vs-Age(81-100Yrs)
2.825200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.373000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.486200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.211600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.960600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.329400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.686000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.522600E-01
Normal-vs-Daily Drinker
3.107400E-01
Normal-vs-Weekly Drinker
4.974200E-01
Normal-vs-Occasional Drinker
1.887620E-01
Normal-vs-Social Drinker
3.666000E-01
Non Drinker-vs-Daily Drinker
7.701600E-01
Non Drinker-vs-Weekly Drinker
6.345000E-01
Non Drinker-vs-Occasional Drinker
7.116600E-01
Non Drinker-vs-Social Drinker
8.223200E-01
Daily Drinker-vs-Weekly Drinker
8.111200E-01
Daily Drinker-vs-Occasional Drinker
9.653800E-01
Daily Drinker-vs-Social Drinker
9.785000E-01
Weekly Drinker-vs-Occasional Drinker
8.247400E-01
Weekly Drinker-vs-Social Drinker
8.040600E-01
Occasional Drinker-vs-Social Drinker
9.458800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.132000E-01
Normal-vs-Grade 2
6.557800E-01
Normal-vs-Grade 3
6.711600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.892200E-01
Grade 1-vs-Grade 3
1.792040E-01
Grade 1-vs-Grade 4
6.132000E-01
Grade 2-vs-Grade 3
4.736400E-01
Grade 2-vs-Grade 4
6.557800E-01
Grade 3-vs-Grade 4
6.711600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.510600E-01
Normal-vs-NonDiabetic
3.111600E-01
Diabetic-vs-NonDiabetic
1.599030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.882400E-02
Normal-vs-NoPancreatitis
3.963000E-01
Pancreatitis-vs-NoPancreatitis
2.587200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.677800E-01
Normal-vs-N1
3.772000E-01
N0-vs-N1
5.952400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.743600E-02
Normal-vs-TP53-NonMutant
5.119000E-01
TP53-Mutant-vs-TP53-NonMutant
7.204100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
